| 1.055 -0.015 (-1.4%) | 05-15 10:10 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.54 | 1-year : | 1.76 |
| Resists | First : | 1.32 | Second : | 1.5 |
| Pivot price | 1.11  |
|||
| Supports | First : | 1.01 | Second : | 0.84 |
| MAs | MA(5) : | 1.08 |
MA(20) : | 1.13 |
| MA(100) : | 1.11 |
MA(250) : | 1.24 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 2.7 |
D(3) : | 3.6 |
| RSI | RSI(14): 43.9 |
|||
| 52-week | High : | 2.38 | Low : | 0.84 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CGC ] has closed above bottom band by 7.6%. Bollinger Bands are 55.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.11 |
| Low: | 1.05 - 1.05 | 1.05 - 1.06 |
| Close: | 1.06 - 1.07 | 1.07 - 1.08 |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Thu, 14 May 2026
Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months - The Motley Fool
Wed, 13 May 2026
WEED.CA Stock Price, Quote & Chart | CANOPY GROWTH CORP (TSX:WEED) - ChartMill
Tue, 12 May 2026
Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Tue, 12 May 2026
Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights - MSN
Tue, 12 May 2026
CGC Stock Price, Quote & Chart | CANOPY GROWTH CORP (NASDAQ:CGC) - ChartMill
Fri, 01 May 2026
Is Canopy Growth Corporation (CGC) Among the Best Hemp Stocks To Buy? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 423 (M) |
| Shares Float | 378 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 10.8 (%) |
| Shares Short | 26,890 (K) |
| Shares Short P.Month | 25,080 (K) |
| EPS | -1.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.5 |
| Profit Margin | -117.4 % |
| Operating Margin | -17.6 % |
| Return on Assets (ttm) | -2.7 % |
| Return on Equity (ttm) | -48.5 % |
| Qtrly Rev. Growth | -0.4 % |
| Gross Profit (p.s.) | 0.17 |
| Sales Per Share | 0.65 |
| EBITDA (p.s.) | -0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -79 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -0.78 |
| PEG Ratio | 0 |
| Price to Book value | 0.69 |
| Price to Sales | 1.59 |
| Price to Cash Flow | -5.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|